Photodynamic Therapy Devices Market Size, Share, By Product (Diode Lasers, Disposable Fiber Optic Light Delivery Devices, and LED-based Devices), Application (Cancer, Actinic Keratosis, Acne, Psoriasis, and Others), End-User (Hospitals, Clinics & Dermatology Centers, and Others), and Region - Trends, Analysis, and Forecast till 2035

• By 2035, the photodynamic therapy devices market share is expected to grow to USD 4.5 Billion.
• Photodynamic therapy devices size was projected USD 2.1 Billion in 2024.
• The market is expanding at a CAGR of 8.2%.

Photodynamic therapy devices (PDT) are used in medical treatments that combine light and a photosensitizing agent to treat certain conditions, such as cancers, skin disorders, and other types of abnormal tissue growth. The devices include laser, LED, and fiber-based devices used to activate the photosensitizer, which destroys the abnormal cells.

Technological advancements, such as lasers, light-emitting diodes, fiber optics, and other specialized tools, and increasing demand for minimally invasive and precise treatment options in various medical fields, led to the growth of the target market growth. Thus, the rising adoption of PDT in healthcare for effective treatment of various conditions, resulting to drive photodynamic therapy devices market growth.

Impact of AI on Photodynamic Therapy Devices Market:

Artificial intelligence (AI) enhances optimized design, personalized treatment plants, and real-time monitoring, by improving treatment efficacy and patient outcomes. AI algorithms can analyze large datasets to identify novel biomarkers and therapeutic targets, leading to the development of photosensitizers with improve tissue penetration, affinity, and target selectivity. AI models can monitor treatment progress in real time, providing feedback to adjust treatment parameters and optimize outcomes.

Key Drivers of Target Market:

Increasing Prevalence of Skin Cancer is Projected to Drive the Market Growth

Skin cancer is the most common type of cancer and is becoming increasingly prevalent. This can be attributed to a combination of factors, including increased exposure to UV radiation, an aging population, and better awareness of the disease. PDT is a promising therapy against various skin cancers, from basal cell carcinoma to squamous cell carcinoma. The increasing burden of skin cancer is likely to increase the demand for PDT devices.

• For instance, according to data published by the International Agency for Research on Cancer, skin cancers are the most common group of cancers diagnosed globally, with more than 1.5 million new cases estimated in 2022. In 2022, an estimated 330,000 new cases of melanoma were diagnosed globally and almost 60,000 people died from the disease. In most regions, melanoma occurs more frequently in men than in women.

Restraints:

High Treatment Costs Distract the Target Market Growth

The costs of PDT devices, photosensitizing agents, and the specialized nature of the procedure make it more expensive than other treatment options. This can limit its adoption, especially in regions with limited economic access to advanced healthcare, and it distracts the PDT devices market growth.

• Counterbalance Statements:  Advances in PDT technology, such as the development of more efficient lasers, LEDs, and photosensitizers, are leading to lower costs of PDT treatments. Integration of AI with PDT devices, allows for more precise and efficient treatment, by reducing labor costs and improving treatment outcomes.

Opportunities & Market Trends:

Integration of AI with PDT Devices Creates Significant Market Opportunity

The integration of AI in PDT devices presents a significant opportunity for growth and innovation. AI can enhance the effectiveness, precision, and accessibility of PDT treatments, creating new avenues for market expansion. AI algorithms can analyze patients’ medical data and clinical history to give personalized PDT treatment plans. AI-powered machine learning helps for image recognition, and real-time decision-making, resulting in driving PDT devices market growth.

The photodynamic therapy devices market is segmented into product, application, end-user, and region.

Product:

By product, the market is segmented into diode lasers, disposable fiber optic light delivery disposable devices, and LED-based devices. The diode lasers dominate the target market due to their efficiency, precision, and ability to target specific tissues. It allows for deep tissue penetration and can used to treat both surface-level and deeper cancer conditions, resulting in driving PDT devices market growth.

• For instance, in April 2022, Lumentum Holding Inc. launched a high-precision FemtoBlade Laser system. The FemtoBlade laser employs a modular design that provides increased flexibility and high power with high repetition rates, which enable faster processing and improved throughput for micromachining applications.

Application:

Based on application, the target market is categorized into, cancer, actinic keratosis, acne, psoriasis, and others. The cancer segment holds the largest photodynamic therapy devices market share. PDT targets cancerous cells with high precision using photosensitizers that selectively accumulate in tumor tissues. The rising incidence of skin cancer and increasing acceptance of PDT as an effective treatment for cancer, have led to the growth of the PDT devices market.

• For instance, in July 2024, Researchers at the University of Notre Dame developed cancer therapy, known as a miniature, wireless LED device that can implant directly into deep-sector tumors. This new approach was aimed to provide the power of light combined with a light-sensitive dye to effectively target and destroy cancer cells while stimulating the body’s immune response against the disease. This activation process converts light into energy, which triggers the production of toxic oxygen within cancer cells, effectively causing them to self-destruct.

End-User:

Photodynamic therapy devices market, by end-user, is divided into hospitals, clinics & dermatology centers, and others. The hospital segment leads the market due to the rising adoption of photodynamic therapy in hospital settings for the treatment of various medical conditions. The growing prevalence of cancer and dermatological disorders rises the demand for effective and non-invasive treatment options, and advancements in photodynamic therapy technologies, leading to the growth of the PDT devices market size.

Region:

Geographically, the market is studied across North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.

North America: This region is dominating in the photodynamic therapy devices market with a share of 37.2%. The increasing healthcare infrastructure, presence of certified professionals, and major key players in the U.S. led to the growth of the target market in the North American region.

• For instance, in November 2024, U.S.-based company Biofrontera announced results from a Phase III trial evaluating its drug-device therapy, Ameluz gel and photodynamic therapy (PDT) with BF-RhodoLED lamp, as a treatment for superficial basal cell carcinoma (sBCC). The Ameluz PDT therapy uses Ameluz, a photosensitizing agent and porphyrin precursor, in combination with a BF-RhodoLED lamp to administer PDT therapy and kill cancerous and precancerous cells.

Asia Pacific: This region is anticipated to be the fastest-growing region in the market over the forecast period. The rising prevalence of skin disorders and cancer, and increasing healthcare investment in countries such as China, India, and Japan, lead to market growth. The improved healthcare accessibility and government funding in healthcare infrastructure, resulting to drive PDT devices market growth.

Photodynamic Therapy Devices Market Report Scope:

Segmentation:

By Product:

• Diode Lasers
• Disposable Fiber Optic Light Delivery Devices
• LED-based Devices

By Application:

• Cancer
• Actinic Keratosis
• Acne
• Psoriasis
• Others

By End-User:

• Hospitals
• Clinics & Dermatology Centers
• Others

By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Russia
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • Indonesia
  • Malaysia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating in the photodynamic therapy devices market include Boston Scientific Corporation, biolitec Holding GmbH & Co KG, Lumibird Medical, and others. Major companies are developing strategies, making collaborations and partnerships with other companies to develop advanced techniques, and introducing more effective technologies in healthcare, resulting in driving photodynamic therapy devices market growth in upcoming years.

Photodynamic Therapy Devices Market Companies:

• Boston Scientific Corporation
• biolitec Holding GmbH & Co KG
• Lumibird Medical
• ShangHai Apolo Medical Technology Co.,Ltd
• Coherent Corp.
• Modulight Corporation
• IRIDEX Corporation
• Candela Corporation
• Cutera Inc.
• Excel Lasers
• Lumenis Be Ltd.
• Sun Pharmaceutical Industries Ltd.
• Novartis AG
• Theralase Technologies Inc.
• Bausch + Lomb

View an Additional List of Companies in the Photodynamic Therapy Devices Market

• In June 2024, Biofrontera launched a U.S. FDA-approved red light LED lamp for patients with actinic keratosis. The new device was used in combination with aminolevulinic acid hydrochloride topical gel, 10% (Ameluz) as photodynamic therapy (PDT) for individuals with actinic keratoses. The introduction of the RhodoLED XL LED lamp provides the option to illuminate a larger area in a single on-label Ameluz PDT treatment. It was designed to be simple and able to accommodate various patient treatments of actinic keratosis.
• In March 2024, Photopharmics announced the initiation of its Celeste light for Photo Dynamic, a clinical trial for Parkinson’s disease. The Celeste phototherapy device uses light to treat symptoms in Parkinson’s patients linked to the circadian system. This is aimed at improving treatment based on functional abilities in photodynamics and is designed primarily for home use for patients. 

Analyst View:

The rising global aging population, and increasing incidences of age-related conditions, such as BPH, Psoriasis, and Actinic Keratosis is leading to market growth. Advances in robotic surgery, AI, and imaging technologies for accurate diagnostics for Actinic Keratosis, and bladder cancer, are anticipated to grow of photodynamic therapy devices market share in upcoming years.

More Related Reports

Enzyme Replacement Therapy Market
Gene Therapy Market
CAR-T Cell Therapy Market
Cell and Gene Therapy Manufacturing Market
Implantable Drug Device Market